Drugs / 13C-Pyruvate
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 01 trial | ||||||
| Phase 0 | NCT03685175 | Jul 2018 → Feb 2025 | breast cancer | University of Texas Southwestern Medical Center | Completed | No outcome recorded |
| Phase 11 trial | ||||||
| Phase 1 | NCT01807702 | Mar → Jul 2013 | — | University of Florida | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 13C-Pyruvate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01807702 ↗ |